COVID-19

An Israeli firm is developing a 30-second coronavirus breath test, a mass screening tool that will help people gain “the confidence to go back and act as normal” amid the coronavirus pandemic.

The U.S. recorded 1,118 COVID-19 deaths on Thursday, the third straight day that the nation topped 1,100 deaths in a single day.

Experts have found that people are more likely to contract COVID-19 at home than outside.

The inhaled form of interferon beta reportedly helps hospitalized COVID-19 patients recover from the disease.

Jared Kushner, Donald Trump’s son-in-law and most influential adviser, recently spoke about his role in the White House and how he deals with criticisms.

A top Russian official has claimed that the country could have a coronavirus vaccine ready by September.

Since the COVID-19 pandemic hit Brazil, there have been more than two million coronavirus cases in the country.

Around 100 scientists are calling for healthy volunteers to become subjects of trials that will test the effectiveness of potential coronavirus vaccines.

Rheumatoid arthritis drug tocilizumab has been found to lower death rates in COVID-19 patients.

A study by Atlanta University has found that radiation therapy can cut hospital stays of COVID-19 patients by helping improve lung conditions and intubation rates.

Experts believe that bats offer clues to treating COVID-19.

Herd immunity may not be possible, suggests the findings of a new study conducted by a team of researchers in the U.K.

Stanford University has debunked attributions of social media posts about avoiding and self-testing for COVID-19 that cite the Stanford Hospital Board as their source.

The next phase of the U.S. trade deal with China is not a priority for Donald Trump.

Microsoft founder Bill Gates believes that availing coronavirus vaccine to the “highest bidder” rather than to the people who need them the most will only cause further devastation as the pandemic could be deadlier in that case.

A COVID-19 survivor from Chicago becomes the second to get a rare double-lung transplant after recovering from the disease.

Research suggests that coronavirus antibodies may last only two to three months.

The European Commission is securing potential treatments for COVID-19 from drug makers Roche and Merck

New evidence suggests that the airborne transmission of coronavirus is possible.

The additional symptoms were observed in a study by researchers at University College London (UCL), wherein they found 43 cases COVID-19 patients who were found to have suffered from temporary brain dysfunction, strokes, nerve damage, or other severe complications. 

A survey conducted by the World Health Organization (WHO) has revealed that 70 countries around the world are at risk of running out of HIV drugs due to the COVID-19 pandemic.

Any potential coronavirus vaccine may not offer lifelong protection against the virus.

More than 200 scientists from different parts of the world have urged the World Health Organization (WHO) to look into the airborne transmission of the novel coronavirus that they suspect could be a possibility.

A new study has shown that the coronavirus that causes COVID-19 has the ability to directly infect the heart.

The United States has finalized a purchasing deal with Gilead Sciences to acquire more than 90% of the global stock of Remdesivir which is the only proven treatment for COVID-19.

A new study has revealed that 250,000 babies and young children may die indirectly due to COVID-19.

Health experts are keeping tabs on a new strain of flu in China. The new virus is carried by pigs and exhibits traits of the 2009 swine flu and 1918 pandemic flu.

A recent analysis from Dr. Jon Thogmartin suggested that COVID-19 patients who appear to be asymptomatic may still be developing "silent" lung damage which does not result in breathing difficulties or cough.

New research suggests that common childhood vaccines may help prevent severe complications of COVID-19.

Researchers at Pirbright Institute have found that two doses of Oxford University’s COVID-19 vaccine boost immune response in pigs better than a single dose.